Dr. Diaby and Colleagues Place Third in PhRMA Foundation’s Diversity Award Contest
Vakaramoko “Karam” Diaby, Ph.D., M.Sc., an assistant professor of pharmaceutical outcomes and policy in the University of Florida College of Pharmacy, led a team of researchers who placed third in the PhRMA Foundation’s Challenge Award contest aimed at addressing health disparities and underrepresented groups in value assessment.
Oragenics Chases Vaccine for Niche Markets
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, seeks to be a major player in the Super Bowl of the pharmaceutical industry: a COVID-19 vaccine.
Juicing AI: University of Florida Taps Computer Vision to Combat Citrus Disease
University of Florida researchers are developing AI applications for agriculture. And the technology - computer vision for smart sprayers - is now being licensed and deployed in pilot tests by an agricultural equipment company.
UF Research Spending at Record $942.2 Million in 2020 Despite Pandemic
University of Florida research spending rose 1.5% to a record $942.2 million in fiscal year 2020, according to a new report to the National Science Foundation.
MJFF Confers Annual J. William Langston Award to Scientific Advisor Malú Gámez Tansey, Ph.D.
This year's recipient of the annual J. William Langston Award from The Michael J Fox Foundation is UF's Malú Gámez Tansey, Ph.D. MJFF CEO Todd Sherer, Ph.D., and chief science officer Brian Fiske, Ph.D., presented Tansey with the award.
UV System Means ‘Lights Out’ for Strawberry Pathogen
A new study led by UF/IFAS researcher shows that UV light kills powdery mildew, a disease that can significantly damage strawberries.
UF Health Names Chief Medical Officer for Central Florida Division
Kevin E. Behrns, M.D., has been appointed chief medical officer for University of Florida Health Central Florida.
University of Florida/IFAS Scientists Provide Insight on Hemp Mites for Growers
For growers contemplating — and who have begun — growing hemp as part of farm trials associated with UF’s Institute of Food and Agricultural Sciences (UF/IFAS) Industrial Hemp Pilot Project, this latest release focuses on lessons learned and provides detailed information on three major groups of mites.
Parent Project Muscular Dystrophy Awards $348,891 Grant to University of Florida Wellstone Center
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy, awarded the University of Florida Wellstone Muscular Dystrophy Cooperative Center a grant for $348,891.
Dialectic Therapeutics Receives FDA Clearance of IND Application for for Its Lead Product Candidate To Treat Cancer
UF startup Dialectic Therapeutics, Inc., a Texas-based biotechnology company focused on creating innovative new technologies to treat cancer, announced that the U.S. Food and Drug Administration (FDA) has concluded that Dialectic may proceed with its clinical investigation for its lead product candidate, DT2216, a unique compound built using its proprietary and novel Antiapoptotic Protein Targeted Degradation (APTaD) technology.
